» Articles » PMID: 31102094

Primary Gallbladder Neuroendocrine Tumors: Insights into a Rare Histology Using a Large National Database

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2019 May 19
PMID 31102094
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary gallbladder neuroendocrine tumors (NETs) are rare, poorly understood cancers infrequently encountered at even the largest of tertiary referral centers. We therefore sought to identify a large cohort of patients with gallbladder NETs using a national database, with the aim of defining treatment modalities employed and survival associated with these uncommon malignancies.

Methods: Patients with primary gallbladder NETs were identified in the National Cancer Database, and clinicopathologic characteristics were recorded. A univariate log-rank survival analysis was completed for patients who underwent resection. Parameters found to be significant were entered into a multivariate accelerated failure time analysis. For context, survival comparisons were included for patients who underwent resections for NETs at any gastrointestinal site and for gallbladder adenocarcinoma.

Results: Overall, 754 patients with gallbladder NETs were identified. Patients were predominantly female (n = 518, 69%), White (n = 503, 67%), presented with stage IV disease (n = 295, 39%) and had high-grade lesions (n = 312, 41%). The majority underwent resection (n = 480, 64%), primarily simple cholecystectomy (n = 431, 90%), whereas a minority received multimodal therapy (n = 145, 21%). Among patients who underwent resection, older age (p = 0.001), large cell histology (p = 0.012), and positive margins (p = 0.030) were independently associated with worse overall survival. Patients with gallbladder NETs had improved survival relative to those with gallbladder adenocarcinoma (p = 0.001), but significantly worse survival than patients with NETs from other gastrointestinal sites (p < 0.001).

Conclusions: Primary gallbladder NETs are aggressive lesions that carry a worse prognosis than NETs of other gastrointestinal sites. Older age, positive margins, and large cell histology are associated with abbreviated survival after resection.

Citing Articles

Demographic and temporal variations in gallbladder adenocarcinoma and neuroendocrine carcinoma: insights from a retrospective analysis of the national cancer database.

Louis M, Ghosh A, Silin N, Dakkak T, Rynarzewska A, Cawthon M Cancer Causes Control. 2025; .

PMID: 39907908 DOI: 10.1007/s10552-025-01967-8.


Targeted gene sequencing and bioinformatics analysis of patients with gallbladder neuroendocrine carcinoma: A case report.

Yang Y, Chen Z, Wan D, Tang H, Liu M World J Gastrointest Oncol. 2025; 17(1):100757.

PMID: 39817132 PMC: 11664618. DOI: 10.4251/wjgo.v17.i1.100757.


Primary gallbladder neuroendocrine neoplasm: A case report of grade 1 well-differentiated neuroendocrine tumor.

Ko A, MacKenzie M, Chiu K, Yap W, Melich G, MacKenzie S Int J Surg Case Rep. 2024; 125:110604.

PMID: 39561576 PMC: 11615934. DOI: 10.1016/j.ijscr.2024.110604.


Clinical diagnosis and treatment of 37 cases of gallbladder neuroendocrine carcinoma.

Liu F, Miao W, Nan J, Shi Z, Zhang A, Bo Y World J Surg Oncol. 2024; 22(1):157.

PMID: 38877554 PMC: 11177431. DOI: 10.1186/s12957-024-03436-z.


Large Cell Neuroendocrine Carcinoma of Gallbladder: A Case Report.

Sah D, Shrestha O JNMA J Nepal Med Assoc. 2024; 62(270):152-154.

PMID: 38409975 PMC: 10924531. DOI: 10.31729/jnma.8444.


References
1.
Duffy A, Capanu M, Abou-Alfa G, Huitzil D, Jarnagin W, Fong Y . Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008; 98(7):485-9. DOI: 10.1002/jso.21141. View

2.
Kasumova G, Tabatabaie O, Najarian R, Callery M, Ng S, Bullock A . Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy. Ann Surg. 2017; 266(4):625-631. DOI: 10.1097/SLA.0000000000002385. View

3.
Soin S, Pannu B, Myint P, Dhillon A . Large cell neuroendocrine carcinoma and adenocarcinoma of gallbladder with concomitant hepatitis C infection. BMJ Case Rep. 2018; 2018. PMC: 6040503. DOI: 10.1136/bcr-2018-225141. View

4.
Fong Y, Wagman L, Gonen M, Crawford J, Reed W, Swanson R . Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006; 243(6):767-71. PMC: 1570569. DOI: 10.1097/01.sla.0000219737.81943.4e. View

5.
Shimizu N, Akashi Y, Fujii T, Shiono H, Yane K, Kitahara T . Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel Fusion Oncokinase. Anticancer Res. 2018; 39(1):413-420. DOI: 10.21873/anticanres.13127. View